All stock lists
Annovis Bio, Inc. (New York Stock Exchange:ANVS)
US · Delayed Price · Currency is USD
Healthcare · Biotechnology
0.84+0.18 (+26.31%)
Market cap
$36.1M
Insider Score
Health Score
Analyst consensus
Listed since
Jan 29, 2020
Website
Insider Score
56/ 100
ANVS Insider Score
Bullish1 qualifying trade · 1 insider · $5.00M bought in the last 90 days
Corporate Lobbying
Government lobbying spending instances
Loading filings…
Source: U.S. Senate LDA
Corporate Lobbying
ANVS Estimated quarterly lobbying spending
Source: U.S. Senate LDA
U.S. Patents
New ANVS patent grants
Loading patent grants…
Source: USPTO Open Data Portal
Government Contracts
Estimated quarterly amount awarded to ANVS from public contracts
Source: USAspending.gov
Recently reported changes in ANVS holdings by institutional investors
Scanning latest 13F filings…
Latest 0 13F filings · Source: SEC EDGAR
View all institutional owners →Congressional Trades
U.S. House and Senate disclosures referencing ANVS, reported under the STOCK Act.
| Politician | Chamber | Action | Amount | Date |
|---|---|---|---|---|
| No congressional trades recorded for ANVS. | ||||
Disclaimer — Informational only — not investment advice. Insider transaction data is sourced from SEC Form 4 filings; market data from public feeds and may be delayed. The Insider Score is a proprietary score for research purposes and does not predict future performance. Always do your own research.